Pharmafile Logo

Manx Home Care

The Mission of Manx Home Care is to introduce the best possible in-home caregiver we can find for our clients. Our employees are carefully selected, screened, and trained to provide professional, compassionate care. We provide Assistants, Podiatrists, Hairdressers and Handyman services. Our professionals will visit you at your home and will give you the care you need.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

12 North Quay, The Care Centre, Douglas, Isle of Man, IM1 4LE, United Kingdom
01624 853899

 Latest Content from PMHub 

Love – it really does make the world go around

No two people are the same nor as individuals are we particularly predictable – we might like to think we are because at some point in time someone decided that...

OPEN Health supports Genetic Alliance UK’s Rare Film Festival!

OPEN Health joined a number of rare disease patients, patient groups and industry representatives at the Regent Street cinema in London to see the winners announced at the Rare Film...

This isn’t goodbye, it’s see you in August!

Bedrock Group imagines, creates and delivers industry-leading benefits

Onyx Health receive national recognition as a “one to watch” business in Newcastle

Press Releases | February 10, 2020 | Onyx Health

Specialist marketing communications agency Onyx Health have been nationally recognised by The Sunday Times as one of six “one to watch” businesses based in Newcastle.

Lighthouse Medical Communications US – An opportunity of a lifetime to be part of the Lucid Group magic

Our family at Lighthouse Medical Communications US are looking for talented individuals to join its team in hashtagManhattan. If you want to be part of something magical get in touch...

Blueberry Therapeutics receives clearance from the FDA to proceed with the clinical investigation of BB2603

Press Releases | February 3, 2020 | Onyx Health

Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to proceed with the clinical development of BB2603

Empowering and equipping medical affairs teams to embrace an ever-expanding remit

Written by Jess Ingram and Francisca Costa, OPEN Health